Antispasmodic drugs Market Size, Share, Trend Analysis and Forecast Report, 2020 - 2027

  • Report ID : MD1495
  • |
  • Pages : 210
  • |
  • Tables : 70
  • |
  • Formats :

Antispasmodic drugs market size was estimated at $XX million in 2020 and is expected to reach $XX Million by 2027, growing at a CAGR of 9.6% during the forecast period of 2020 to 2027.

antispasmodic drugs market

It is a drug that precludes or decreases the risk of muscle spasms, particularly used as muscles relaxant.Specifically, Cardiac, Smooth and Skeleton muscles in the human body can cause muscles spasm. It can be classified as Antimuscarinics or Anticholinergic which includes Propantheline, Atropine, Hyoscine, Dicylcomine and Butylbromide where as Smooth muscle relaxants includes Mebeverine, Drotaverine, peppermint Oil and Alverine.Antispasmodic drugs have a wide class of medication which is prescribed to treat to complaint of relaxation and contraction of muscles. Some of these medical conditions are overactive bladder, gastrointestinal cramps, breathing problems, irritable bowel syndrome, diarrhea and others.

Antispasmodic Drugs Market Growth and Trends

Antispasmodics and anticholinergic owing to effective benefits in causing relief from cramps and spasms of the intestine, stomach, and bladder trigger a high demand in the market. Used in combination with antacids and other medicines for treating ulcers, nausea, and motion sickness they further foster demand. Their efficiency in treating poisoning caused by various medicines, mushrooms, and organic pesticides adds to their use benefits. The cases of gastrointestinal diseases and disorders are increasing rapidly throughout the globe under the influence of factors, such as aging population, and modified lifestyle is an emerging trend expected to propel the demand for the antispasmodic and anticholinergic H2 blocking agents in the future. The large ammonium side chain in the synthetic quaternary ammonium derivatives makes these derivatives less likely to cross membranes such as the blood brain barrier, and therefore they are less likely to affect the central nervous system.  Antimuscarinic antispasmodic agents atropine and related belladonna alkaloids, and the synthetic antimuscarinics are used in the treatment of muscle spasm: anticholinergics lead to a dramatic effect on smooth muscle spasm in the case of intravenous administration, but oral administration may lead to an unfavourable effect; and for the suppression of gastric acid secretion, where the high doses required may be associated with certain side-effects. More selective gastric acid antisecretory agents are preferred and have considerably superseded agents that were formally used. In treating the irritable bowel syndrome, a high-fibre maintenance diet combined with short-term antispasmodics is often beneficial.

Synthetic drugs are commercially produced by drug manufacturers for valid medical purposes, which may, however, lead to diversion from legal channels across the globe. A background in chemistry, laboratory control knowledge, and an educated understanding of the process is usually required for successful and safe synthesis of these drugs, a dearth of which could be challenging.


Need report on this market for specific Region or Country? OR Need a customized report as per your need? Want to know discounts available?

Email US

David Correa

OR Fill the below "Sample Request Form" With your queries in message box.


20% Free Customization ON ALL PURCHASE

*Terms & Conditions Apply

Request Free Sample

Please fill in the form below to Request for free Sample Report

  • Office Hours Mon - Sat   10:00 - 16:00

  • Send Us Mail